Skip to main content

Table 2 Clinical chemistry profiles of the study group

From: Association between erythrocyte Na+K+-ATPase activity and some blood lipids in type 1 diabetic patients from Lagos, Nigeria

Parameter Control Type 1 diabetic patients
   A1 (n = 20) A2 (n = 14) Total (n = 34)
FBS, mmole/L 5.0 ± 0.2 6.1 ± 0.3ab 5.2 ± 0.2 5.5 ± 0.5a
TC, mg/dL 173.8 ± 7.4 190.3 ± 15.9ab 178.4 ± 6.9a 182.7 ± 12.2a
LDL-C, mg/dL 107.6 ± 6.8 128.1 ± 15.1ab 111.0 ± 9.3 184.2 ± 12.6a
HDL-C, mg/dL 42.2 ± 5.3 33.1 ± 2.6ab 40.7 ± 3.5 38.1 ± 4.7a
TAG, mg/dL 120.4 ± 7.5 145.3 ± 13.3ab 133.4 ± 9.7a 137.1 ± 11.3a
Hypercholesterolemia, n(%) 0(0) 3 (8.8) 0(0) 3 (8.8)
Elevated LDL-C, n(%) 0(0) 2 (5.9) 0(0) 2 (5.9)
Hypertriglyceridemia, n(%) 0(0) 1 (2.9) 0(0) 1 (2.9)
Reduced HDL-C, n(%) 3 (11.1) 5 (14.7) 1(2.9) 6 (17.6)
  1. Data are expressed as mean ± SD and analyzed using Student's t-test (2-tail).
  2. aP < 0.05 (control vs. IDDM patients), bP < 0.05 (A1 vs. A2). P <0.05 was considered significant.